331 related articles for article (PubMed ID: 842614)
1. Immune adherence in renal glomeruli. Complement receptor sites on glomerular capillary epithelial cells.
Burkholder PM; Oberley TD; Barber TA; Beacom A; Koehler C
Am J Pathol; 1977 Mar; 86(3):635-54. PubMed ID: 842614
[TBL] [Abstract][Full Text] [Related]
2. Localization of receptors for activated complement on visceral epithelial cells of the human renal glomerulus.
Shin ML; Gelfand MC; Nagle RB; Carlo JR; Green I; Frank MM
J Immunol; 1977 Mar; 118(3):869-73. PubMed ID: 845439
[TBL] [Abstract][Full Text] [Related]
3. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
[TBL] [Abstract][Full Text] [Related]
4. The glomerular complement receptor in immunologically mediated renal glomerular injury.
Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
6. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
7. Interaction of antibodies with human glomerular epithelial cells.
Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
[TBL] [Abstract][Full Text] [Related]
8. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
[TBL] [Abstract][Full Text] [Related]
9. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
Arend WP; Massoni RJ
Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
[TBL] [Abstract][Full Text] [Related]
10. Localization of cationic proteins derived from platelets and polymorphonuclear neutrophils and local loss of anionic sites in glomeruli of rabbits with experimentally-induced acute serum sickness.
Camussi G; Tetta C; Meroni M; Torri-Tarelli L; Roffinello C; Alberton A; Deregibus C; Sessa A
Lab Invest; 1986 Jul; 55(1):56-62. PubMed ID: 3724064
[TBL] [Abstract][Full Text] [Related]
11. C3b receptors in glomerular disease.
Moran J; Colasanti G; Amos N; Peters DK
Clin Exp Immunol; 1977 May; 28(2):212-7. PubMed ID: 406109
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
[TBL] [Abstract][Full Text] [Related]
13. Abnormal podocyte CR-1 expression in glomerular diseases: association with glomerular cell proliferation and monocyte infiltration.
Nolasco FE; Cameron JS; Hartley B; Coelho RA; Hildredth G; Reuben R
Nephrol Dial Transplant; 1987; 2(5):304-12. PubMed ID: 2962013
[TBL] [Abstract][Full Text] [Related]
14. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
Okada H; Okada N
Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
[TBL] [Abstract][Full Text] [Related]
15. Glomerular localization of platelet cationic proteins after immune complex-induced platelet activation.
Barnes Jl; Camussi G; Tetta C; Venkatachalam MA
Lab Invest; 1990 Dec; 63(6):755-61. PubMed ID: 2255184
[TBL] [Abstract][Full Text] [Related]
16. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
[TBL] [Abstract][Full Text] [Related]
17. Control of Fc and C3 receptors on myeloid leukemic cells.
Lotem J; Sachs L
J Immunol; 1976 Aug; 117(2):580-6. PubMed ID: 950462
[TBL] [Abstract][Full Text] [Related]
18. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
Carlo JR; Ruddy S; Studer EJ; Conrad DH
J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
[TBL] [Abstract][Full Text] [Related]
19. Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens.
Gauthier VJ; Striker GE; Mannik M
Lab Invest; 1984 Jun; 50(6):636-44. PubMed ID: 6374284
[TBL] [Abstract][Full Text] [Related]
20. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
